Antibiotics, Antitubercular
- Name
- Antibiotics, Antitubercular
- Accession Number
- DBCAT000630
- Description
Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.
- Drugs
Drug Drug Description Cycloserine A broad-spectrum antibiotic used in the treatment of tuberculosis and certain urinary tract infections (UTI). Capreomycin An aminoglycoside antibiotic used as an adjunct drug in tuberculosis. Rifabutin An antibiotic used to treat mycobacterium avium complex disease in patients with HIV. Amprenavir A protease inhibitor used to treat HIV infection. Rifampicin An antibiotic used to treat several types of mycobacterial infections including Mycobacterium avium complex, leprosy, and in combination with other antibacterials to treat latent or active tuberculosis. Rifapentine An antibiotic agent used in the treatment of pulmonary tuberculosis. Rifalazil Investigated for use/treatment in atherosclerosis, bacterial infection, and peripheral vascular disease. Viomycin Viomycin is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis. Enviomycin Cyclic basic peptide related to viomycin. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin. Mycophenolate mofetil An inosine monophosphate dehydrogenase inhibitor used to prevent the rejection of kidney, heart, or liver transplants. - Drugs & Drug Targets